Clinical trial Recruiting at 1 site Observational Ages 18 to 85

Evaluating inflammation changes in patients after heart rhythm procedure

Official title: Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation

Run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT05961865 · Data updated 2026-11-12

This study looks at how inflammation and fat levels change in people aged 18 to 85 after they have a heart procedure to treat atrial fibrillation.

Quick facts

Study typeObservational
Ages18 Years to 85 Years
SexAll
Enrollment180 (estimated)
SponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Academic / other
Locations1 site (Milan)
StatusRecruiting
StartedJuly 11, 2023
Main results expectedJuly 2027
Study endsAugust 2027
Registry record updatedSeptember 13, 2023
Trial IDNCT05961865 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 85 with paroxysmal or persistent atrial fibrillation scheduled for catheter ablation.

Probably not a fit

Patients over 85 years old, those with severe comorbidities, or contraindications to the procedure may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the relationship between inflammation markers and local fat levels in patients undergoing catheter ablation for atrial fibrillation. It will analyze various inflammation and fibrosis markers, including Interleukin 6 and tumor necrosis factor, at different time points before and after the procedure. The study will include patients aged 18 to 85 who meet specific clinical criteria and can provide informed consent.

Why it matters

Potential benefit: If successful, this study could enhance understanding of inflammation's role in atrial fibrillation and improve patient outcomes post-ablation.

How similar studies have gone: Other studies have explored inflammation in relation to atrial fibrillation, suggesting potential for meaningful insights, though this specific approach may be novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Paroxysmal or persistent AF;
* Patients undergoing ESC/ERAH(European Society of Cardiology/European Heart Rhythm Association) approved catheter ablation procedures;
* Aged between 18 and 85 years;
* Ability to provide informed consent for study participation.

Exclusion Criteria:

* Age \> 85 years or \< 18 years;
* Presence of left auricular thrombosis on pre-procedural transesophageal echocardiogram;
* NYHA functional class IV;
* Left ventricular ejection fraction \<30%;
* Myocardial infarction or unstable angina or recent coronary artery bypass graft (\<6 months);
* Significant co-morbidity, such as cancer, severe renal failure requiring dialysis, severe obstructive pulmonary disease, cirrhosis, with a life expectancy of less than 12 months;
* Presence of contraindications to the procedure;
* Inability to provide informed consent for study participation.

Where it's running

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
    Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.